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Introduction
●   The DAWN2 study explored the perceptions of PWD, HCPs 
and FMs in 17 countries, focusing primarily on the psychosocial 
aspects of diabetes, its management, and improvements 
needed in areas of care and support.1
●   The findings are considered benchmarks for psychosocial 
indicators related to the impact, burden, distress and 
depression experienced by PWD and FMs, and for diabetes 
management and education particularly identified by HCPs.2–4
●   Improvements in the care and supports to help PWD manage 
their diabetes, including the psychosocial aspects, were 
identified.2 Improved access and availability to psychological 
and support resources, experts and education, were 
identified by HCPs.4
●   A secondary study of DAWN2 was a situational analysis 
conducted in 2012 on existing policies in each of the  
17 countries, for patient-centred psychological care and 
supports, and diabetes treatment and reimbursement.1
Aim
●   The aim of this poster is to present the situational analysis 
of existing diabetes-related policies and strategies in the  
17 countries specifically relevant to the management and 
care of the psychological/psychosocial aspects of diabetes.
Methods
Study design
●   The full study design for the DAWN2 study has been 
previously described.1   
●   Briefly, DAWN2 is an international, interdisciplinary,  
multi-stakeholder study conducted in 17 countries across 
four continents.
●   DAWN2 was conducted in accordance with relevant ethical 
requirements in each country.
●   The DAWN2 survey methodology regarding PWD, FMs and 
HCPs participation and needs concerning diabetes education 
and training are published elsewhere.1–4 This methodology 
includes the recruitment of PWD, HCPs and FMs across the 
17 countries, and the use of validated, adapted and new 
questions specific to diabetes education participation. 
Global (overall) scores were reported as mean % with country 
variations expressed as minimum to maximum mean % range.
●   The country policy/situational assessments were undertaken 
in five steps:1
–   scoping review process: document searches on 
electronic databases
–   desk research through literature review and 
synthesis: guided by four topic areas (patient 
involvement, equal access to care, self-management 
education and psychosocial support)
–   in-depth questionnaire-based interviews in each 
participating country: interviewees with experience/
knowledge of country policies/strategies were selected 
with the support of the national DAWN2 expert network 
and represented key national stakeholder groups (patient 
organisation, diabetes expert/advisor to government, 
policymaker)
–   ranking of performance on each indicator in each 
country: experts ranked 28 identified indicators across 
countries using a ranking scale between 2 to 10, and 
categorised as: 1 (no information); 2–4 (no policies/
strategies in place); 5–7 (policies/strategies in place and 
only partially endorsed or implemented); and 8–10 (policies/ 
strategies in place and fully endorsed and in practice)
–   validating research by matching findings with 
interview data and expert committee.
Results
●   Survey results of experiences and perceptions of 8,596 PWD 
were previously published2 as were perceptions of 4,785 HCPs 
regarding treatment, care, education and supports for PWD.3
●   Twelve policy and strategy indicators from the situational 
analysis were definitive across all 17 countries, three of 
which related specifically to psychosocial aspects of diabetes 
and care (see Table 1).
●   Results in this poster are presented under the three selected 
indicators.
(1)  Government policy includes or endorses 
evidence-based guidelines on management 
of psychosocial aspects of diabetes
●   Results of the 2012 situational analysis of country policies 
pertaining to this indicator, suggest that:
–   29% of HCPs indicated that their countries (Mexico, Spain, 
Denmark, the UK and France) have a government policy 
that includes or endorses national guidelines on psychosocial 
management. An equal number have no policies in place 
for this (India, Japan, Turkey, Algeria and China). Another 
42% of countries are either developing or have existing 
policies but have not endorsed them (Figure 1)
–   more countries have clinical guidelines and medications 
for treatment of diabetes than they have clinical guidelines 
for psychological issues management
–   there are discrepancies in the situational/policy data 
compared with the HCP survey responses regarding 
psychological issues management in the following two 
examples:
   in the situational responses, China and India scored 
2–4 meaning that they do not have any policies/
strategies or guidelines in place regarding psychological 
issues management. However, a significant percentage 
of HCPs clearly indicated that clinical guidelines for 
psychological issues management are in place and 
used in both China (78%) and India (64%)
   Spain was one country which scored 8–10 for having 
guidelines in place and having them endorsed and used, 
but only 20% of HCPs in Spain indicated that they had 
guidelines in place for psychological issues management.
Figure 1. Percent of countries in each of the four score clusters 
described as: 1 = no information available; 2–4 = no government 
policy includes or endorses guidelines of diabetes, and no unofficial 
guidelines exist; 5–7 = government policy on psychosocial 
management of diabetes is in development/exist but is not 
endorsed; 8–10 = government policy includes or endorses national 
guidelines on psychosocial management.
●   Relevant to the situational policy analysis are considerations 
of DAWN2 survey results for PWD2 and HCPs3 which 
indicate that:
–   58.8% of PWDs (range 18.5–67.6) said they were satisfied 
that their care was well organised ‘most of the time’/’always’
–   29.6% of HCPs (range 7.4–67.1) agreed that healthcare 
in their countries was well organised for the management 
of chronic conditions, and 49.6% agreed that diabetes 
should be given a higher priority than it currently receives
–   28.3% (15.5–78.4) said that practical clinical guidelines 
for management of psychosocial issues related to diabetes 
were in place for their practice. Country responses are 
shown in Figure 2
–   53.7% (32.1–70.9) claimed that clinical guidelines and 
medications for pharmacological treatment of depression 
or anxiety were in place for their practice. Country 
responses are shown in Figure 2.
Figure 2. Percent of HCPs responses in each of the 17 countries 
regarding practical clinical guidelines for management of 
psychosocial issues related to diabetes, and clinical guidelines and 
medications for pharmacological treatment of depression or anxiety.
(2)  Regular QoL/mental health assessment in 
diabetes care standards
●   Results of the 2012 situational analysis of country policies 
pertaining to this indicator, shown in Figure 3, suggest that:
–   with this indicator, 47% of countries had formal standards 
recommending regular QoL/mental health assessment 
but implementation is not widely done
–   another 41% had formal care standards but they did not 
mention monitoring of regular QoL/mental health
–   only the UK had formal care standards in place which 
required regular QoL/mental health monitoring to be done 
as part of standard diabetes care. This finding does not 
correspond with the discrepancies found in the survey 
findings for 16% of PWD who said they had been asked 
by HCPs if they had been anxious or depressed, and for 
46% of HCPs who said they asked their patients how 
diabetes affected their lives.
Figure 3. Percent of countries in each of the four score clusters 
described as: 1 = no information available; 2–4 = formal care 
standards do not mention monitoring of regular QoL/mental health; 
5–7 = formal care standards recommend QoL/mental health 
monitoring but implementation is not widely done; 8–10 = formal 
care standards require regular QoL/mental health monitoring to be 
done as part of standard diabetes care.
●   Relevant to the situational policy analysis are considerations 
of DAWN2 survey results for PWD2 and HCPs3 which 
indicate that:
–   about 13% of PWD indicated having a ‘poor’/’very poor’ 
QoL (country range: 7.6–26.1) and experienced ‘likely’ 
depression (range: 6.5–24.1)
–   42.6% of PWD across the 17 countries experienced high 
distress living with and managing diabetes. Countries in 
which PWD reported distress higher than the global 
mean value included Mexico, Italy, Spain, Poland, Russia, 
Algeria, Turkey, India and China. The USA, Canada, France, 
Germany, Netherlands, Denmark, the UK and Japan 
reported distress values below the global mean value
–   less than one-third of PWD said that in the past 12 months 
they had been asked by their HCPs whether they were 
anxious or depressed (31.9% [range 14.6–57.3])
–   less than one-quarter of PWD were asked by their HCPs 
how diabetes affected their lives ‘most of the time’/’always’ 
(23.7% PWD [range 6.6–45.1]). Countries in which PWD 
responses were at or above the global mean of 23.7% 
were Mexico, Spain, Poland, Turkey, India and China
–   50.7% of HCPs (country range 34.0–74.6) said they asked 
their patients how diabetes affected their lives ‘most of 
the time’/’always’. Countries in which HCP responses were 
at or above the global mean % were Mexico, Netherlands, 
Italy, Russia, Algeria, Turkey, India, and China.
(3)  Reimbursement of psychological care for PWD
●   Results of the 2012 situational analysis of country policies 
pertaining to this indicator, shown in Figure 4, suggest that:
–   29% of countries have reimbursement for psychological 
care for PWD
–   59% have partial coverage in place
–   two of the 17 countries have no reimbursement in place 
(France and Russia). However, survey responses of 37% 
of HCPs in France concerning the need for resources for 
the provision of psychological support and care for 
diabetes, was lower than all but two other countries
–   of the five countries which scored 8–10 on having 
psychological care reimbursed for PWD, Poland and Algeria 
had some of the highest need of all countries for resources 
for the provision of psychological support and care.
Figure 4. Percent of countries at each of the four score clusters 
described as: 1 = no information available; 2–4 = psychological care 
for PWD is not reimbursed; 5–7 = psychological care for PWD is 
only partially reimbursed or requires special/additional/membership/
insurance; 8–10 = psychological care for PWD is reimbursed for all 
patients’ diabetes care.
●   Relevant to the situational policy analysis are considerations 
of DAWN2 survey results for HCPs3 (Figure 5) which indicate 
that:
–   12.1% of HCPs (range 5.5–27.9) said they had no resources 
to offer patients who are emotionally distressed or at risk 
of depression (country responses shown in Figure 5)
–   65.7% of HCPs (range 40.6–79.6) felt that one area 
needing improvement was the availability of resources for 
the provision of psychological support and care for their 
patients
–   58.2% of HCPs (range 27.6–83.9) indicated that there 
should be better access to psychologists or psychiatrists 
for referral
–   49.2% of HCPs (range 13.3–80.0) said that the healthcare 
remuneration system is a barrier to effective diabetes 
management (Figure 5)
–   5.8% (range 0.8–36.7) were reimbursed for their time spent 
to evaluate and counsel regarding psychological issues 
(Figure 5). 
Figure 5. Percent responses of HCPs by country, regarding lack of 
and need for psychological resources to offer PWD as well as 
reimbursement for their time evaluating and counselling PWD, and 
whether healthcare remuneration was a barrier to effective 
diabetes management.
Summary of three indicators by country
●   Countries which were consistently above average on each 
indicator as well as combined included the UK, Poland, 
Netherlands, Italy, Denmark, France, the USA and Canada. 
For these countries, policies or strategies were either being 
developed or existing and were being implemented in some 
way (Figure 6).
●   Of these countries, less than 33% of HCPs in the USA, UK, 
Italy, Canada and the Netherlands indicated that clinical 
guidelines for psychological issues management were in 
place, and 50% or more in the UK, Poland and Canada 
indicated that they needed more psychological support/care 
resources (Figures 2, 5 and 6).
Figure 6. Country scores for the three indicators for psychosocial 
care related to diabetes.
●   Globally, most countries have policies/strategies endorsing 
practice guidelines, diabetes care standards for regular  
QoL/mental health assessments and reimbursement of 
psychological care for PWDs, but they are not fully 
implemented or applied (Figure 7).
●   29% of countries have implemented policies which endorsed 
guidelines on management of psychosocial aspects of 
diabetes and reimbursed psychological care for PWD.
●   Over 40% of countries have no diabetes standards 
regarding regular QoL/mental health assessment. Only one 
country has implemented this. 
Figure 7. Global situational analysis of policies for guidelines, 
diabetes care standards and reimbursement of psychological care.
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Conclusions
●   The DAWN2 findings emphasise the importance of 
having national person-centred diabetes care policies 
supporting clinical guidelines or standards of care that 
include regular psychosocial assessments, and 
reimbursement of psychological care as part of routine 
diabetes care.
●   The responses of HCPs and PWD across the 17 countries 
confirm the need for policies, diabetes care standards 
and reimbursement for psychological aspects of diabetes.
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Table 1. Twelve policy and strategy indicators selected across  
17 countries
Indicators for country diabetes-related policies and strategies
●   Structured national diabetes policy supporting delivery of  
person-centred care
●   Patients/patient organisations involved in structured national  
diabetes policy drafting process
●   Patient feedback is part of ongoing diabetes quality care and 
evaluation
●   Legislative support for the right of PWD to receive quality  
self-management education
●   Reimbursement of diabetes self-management education
●   Government policy addresses special educational needs in diabetes 
subpopulations
●   Government policy includes or endorses quality standards for diabetes 
self-management education
●   Certified education for diabetes HCPs in patient-centred care
●   Tele-health and IT solutions to empower self-management by PWD is 
part of government policy
●   Government policy includes or endorses evidence-based guidelines 
on management of psychosocial aspects of diabetes
●   Regular QoL/mental health assessment in diabetes care standards
●   Reimbursement of psychological care for PWD
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